IDWeek 2026: novel antifungal turletricin demonstrates positive Phase II results
The data presented at IDWeek is from the Phase II portion of the Platform Trial for Cryptococcal Meningitis (PLATFORM-CM).
The data presented at IDWeek is from the Phase II portion of the Platform Trial for Cryptococcal Meningitis (PLATFORM-CM).